Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 12 filings

Top spenders & firms Spend by issue

Clear
Q1
MONUMENT ADVOCACY for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Trade (domestic/foreign), Taxation/Internal Revenue Code
View →
Q1
BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $90,000.00 income
Health Issues
View →
Q1
TODD STRATEGY GROUP for NOVARTIS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q1
TARPLIN, DOWNS & YOUNG, LLC for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Budget/Appropriations, Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q1
TIBER CREEK GROUP for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Trade (domestic/foreign)
View →
Q1Y
TIBER CREEK HEALTH STRATEGIES, INC. for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $60,000.00 income
View →
Q1
DLA PIPER LLP (US) for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Copyright/Patent/Trademark, Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues
View →
Q1
BGR GOVERNMENT AFFAIRS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
NOVARTIS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View →
Q1
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Trade (domestic/foreign), Health Issues
View →
Q1
FORBES-TATE for NOVARTIS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Taxation/Internal Revenue Code, Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q1
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem